Globus Medical (GMED)

Currency in USD
81.46
+2.67(+3.39%)
Closed·
81.460.00(0.00%)
·
GMED is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
79.5481.72
52 wk Range
52.68101.40
Key Statistics
Prev. Close
78.79
Open
80.36
Day's Range
79.54-81.72
52 wk Range
52.68-101.4
Volume
914.16K
Average Volume (3m)
1.85M
1-Year Change
51.8926%
Book Value / Share
34.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GMED Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
103.92
Upside
+27.58%
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Globus Medical News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

10 Buy
5 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 103.92
(+27.58% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Hold82.00+0.66%-New CoverageJul 28, 2026
Truist Securities
Buy100.00+22.76%115.00MaintainJul 16, 2026
RBC Capital
Buy115.00+41.17%120.00MaintainJul 13, 2026
BMO Capital
Buy---New CoverageJul 08, 2026
Stifel
Hold80.00-1.79%95.00MaintainJul 08, 2026

Globus Medical SWOT Analysis


Spine Market Leade
Globus Medical demonstrates sustained double-digit growth in U.S. Spine division, outperforming projections while expanding market share through differentiated technologies and enhanced sales effectiveness
Analyst Perspectives
Average price target stands at $113, with Overweight ratings reflecting confidence in the company's growth trajectory and operational execution across multiple business segments
Robotics Revolution
The surgical robotics platform consistently surpasses expectations, leveraging established surgeon relationships to accelerate adoption and capture share in next-generation spine procedures
Nevro Synergies
Acquisition integration progresses ahead of schedule with EBITDA margins reaching impressive levels, while diversification into pain management expands addressable markets beyond traditional surgery
Read full SWOT analysis

Globus Medical Earnings Call Summary for Q1/2026

  • Q1 2026 EPS of $1.12 beat forecast of $0.92 by 21.8%; revenue hit $759.9M, up 27% YoY, exceeding expectations by 2.64%
  • Gross margin improved to 66.4% from 63.6% YoY; adjusted EBITDA margin reached 32.3%, reflecting strong cost efficiency gains
  • Stock fell 4.65% to $88.35 in after-hours trading despite earnings beat, potentially due to broader market conditions
  • Q2 2026 EPS guidance set at $1.07 with revenue forecast of $793.62M; Q3 targets $1.17 EPS and $807.32M revenue
  • Nevro acquisition integration on track, contributing to revenue growth; CEO cited successful strategic execution and product innovation
Last Updated: 2026-05-07, 10:02 p/m
Read Full Transcript

Earnings

Latest Release
May 07, 2026
EPS / Forecast
1.12 / 0.92
Revenue / Forecast
759.85M / 740.34M
EPS Revisions
Last 90 days

GMED Income Statement

Compare GMED to Peers and Sector

Metrics to compare
GMED
Peers
Sector
Relationship
P/E Ratio
18.8x5.9x−0.4x
PEG Ratio
0.08−1.200.00
Price/Book
2.3x4.9x2.6x
Price / LTM Sales
3.6x3.6x3.0x
Upside (Analyst Target)
30.7%26.1%54.3%
Fair Value Upside
Unlock3.6%8.4%Unlock

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
60.45M44.53%4.76B
Other Institutional Investors
53.02M39.06%4.18B
Public Companies & Retail Investors
22.28M16.41%1.76B
Total
135.74M100.00%10.7B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.7.73%10,497,414827,091
Janus Henderson Group Ltd.5.62%7,623,095600,624

People Also Watch

58.70
FOXA
+0.81%
67.07
PNR
+2.49%
101.12
ACGL
+0.59%
157.34
BR
+2.20%
162.28
MKTX
-0.01%

FAQ

What Is the Globus Medical (GMED) Stock Price Today?

The Globus Medical stock price today is 81.46 USD.

What Stock Exchange Does Globus Medical Trade On?

Globus Medical is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Globus Medical?

The stock symbol for Globus Medical is "GMED."

What Is the Globus Medical Market Cap?

As of today, Globus Medical market cap is 11.06B USD.

What Is Globus Medical's Earnings Per Share (TTM)?

The Globus Medical EPS (TTM) is 4.29.

When Is the Next Globus Medical Earnings Date?

Globus Medical will release its next earnings report on Aug 06, 2026.

From a Technical Analysis Perspective, Is GMED a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Globus Medical Stock Split?

Globus Medical has split 0 times.

How Many Employees Does Globus Medical Have?

Globus Medical has 6000 employees.

What is the current trading status of Globus Medical (GMED)?

As of Aug 04, 2026, Globus Medical (GMED) is trading at a price of 81.46 USD, with a previous close of 78.79 USD. The stock has fluctuated within a day range of 79.54 USD to 81.72 USD, while its 52-week range spans from 52.68 USD to 101.40 USD.

What Is Globus Medical (GMED) Price Target According to Analysts?

The average 12-month price target for Globus Medical is 103.92 USD, with a high estimate of 122 USD and a low estimate of 82 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +27.58% Upside potential.

What Is the GMED Premarket Price?

GMED's last pre-market stock price is 76.02 USD. The pre-market share volume is 110.00, and the stock has decreased by -2.77, or -3.52%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.